@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://linked.opendata.cz/ontology/drug-encyclopedia/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<http://linked.opendata.cz/resource/ATC/L> a ns1:ATCConcept ;
    dcterms:title "Cytostatika a imunomodulační léčiva"@cs,
        "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS"@en ;
    skos:notation "L" .

<http://linked.opendata.cz/resource/ATC/L02> a ns1:ATCConcept ;
    dcterms:title "Hormonální léčiva používaná v onkologii"@cs,
        "ENDOCRINE THERAPY"@en ;
    skos:notation "L02" .

<http://linked.opendata.cz/resource/ATC/L02A> a ns1:ATCConcept ;
    dcterms:title "Hormony a příbuzné látky"@cs,
        "HORMONES AND RELATED AGENTS"@en ;
    skos:notation "L02A" .

<http://linked.opendata.cz/resource/ATC/L02AE> a ns1:ATCConcept ;
    dcterms:title "Analogy gonadotropin-releasing hormonu"@cs,
        "Gonadotropin releasing hormone analogues"@en ;
    skos:notation "L02AE" .

<http://linked.opendata.cz/resource/ATC/L02AE02> a ns1:ATCConcept ;
    dcterms:title "Leuprorelin"@cs,
        "Leuprorelin"@en ;
    skos:broaderTransitive <http://linked.opendata.cz/resource/ATC/L>,
        <http://linked.opendata.cz/resource/ATC/L02>,
        <http://linked.opendata.cz/resource/ATC/L02A>,
        <http://linked.opendata.cz/resource/ATC/L02AE> ;
    skos:notation "L02AE02" .

<http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0025473> a ns1:Ingredient ;
    ns1:contraindicatedWith <http://linked.opendata.cz/resource/ndfrt/disease/N0000000999>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000010195>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000010216> ;
    ns1:description "A potent synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE that regulates the synthesis and release of pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE.     "@en ;
    ns1:hasPharmacologicalAction <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0008372>,
        <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0028300> ;
    ns1:hasPregnancyCategory <http://linked.opendata.cz/resource/fda-spl/pregnancy-category/X> ;
    ns1:title "Leuprolid"@cs,
        "Leuprolide"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0008372> a ns1:PharmacologicalAction ;
    ns1:description "Compounds which increase the capacity to conceive in females.     "@en ;
    ns1:title "Fertilizující látky ženské"@cs,
        "Fertility agents, female"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0028300> a ns1:PharmacologicalAction ;
    ns1:description "Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079)     "@en ;
    ns1:title "Antitumorózní látky hormonální"@cs,
        "Antineoplastic agents, hormonal"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000999> a ns1:DiseaseOrFinding ;
    ns1:title "Léková alergie"@cs,
        "Drug hypersensitivity"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000010195> a ns1:DiseaseOrFinding ;
    ns1:title "Těhotenství"@cs,
        "Pregnancy"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000010216> a ns1:DiseaseOrFinding ;
    ns1:title "Laktace"@cs,
        "Lactation"@en .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0183644> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/L02AE02> ;
    ns1:hasIndication """Lutrate Depot 3,75 mg je určen k paliativní léčbě lokálně pokročilého nebo metastatického karcinomu prostaty.
"""@cs ;
    ns1:hasIndicationGroup "HORMONA (LÉČIVA S HORMONÁLNÍ AKTIVITOU)"@cs ;
    ns1:hasPackagingSize "1+1X2ML ISP"^^xsd:string ;
    ns1:hasRegistrationState <http://linked.opendata.cz/resource/sukl/registration-state/R> ;
    ns1:hasRouteOfAdministration "Injekce"@cs ;
    ns1:hasSPCDocument <http://linked.opendata.cz/resource/sukl/spc/document/SPC156384_doc> ;
    ns1:hasStrength "3.75MG"^^xsd:string ;
    ns1:hasTitleSupplement "INJ PLQ SUS PRO 1X3.75+SOLV"@cs ;
    ns1:title "LUTRATE DEPOT 3,75 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/LUTRATE-DEPOT-3-75-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/L02AE02> ;
    ns1:hasActiveIngredient <http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0025473> ;
    ns1:hasMedicinalProductPackaging <http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0183644> ;
    ns1:hasPregnancyCategory <http://linked.opendata.cz/resource/fda-spl/pregnancy-category/X> ;
    ns1:title "LUTRATE DEPOT 3,75 MG"@cs .


